Carrie Schmidt
Psychiatric/Mental Health · Davenport, IANPI 1952122012
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,864, more than ten times the $6 reported in 2023.
Across 149 payments — averaging $24.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$549
- AbbVie$455
- Teva Pharmaceuticals USA, Inc.$444
- Otsuka America Pharmaceutical, Inc.$432
- E.r. Squibb & Sons, L.L.C.$348
- Alkermes, Inc.$302
- plus $1K from 12 others
What the payments were for
- Food & beverage$3,628100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $549 |
| AbbVie | 22 | $455 |
| Teva Pharmaceuticals USA, Inc. | 10 | $444 |
| Otsuka America Pharmaceutical, Inc. | 24 | $432 |
| E.r. Squibb & Sons, L.L.C. | 12 | $348 |
| Alkermes, Inc. | 10 | $302 |
| Axsome Therapeutics, Inc. | 4 | $292 |
| Neurocrine Biosciences, Inc. | 18 | $266 |
| Johnson & Johnson | 5 | $185 |
| Braeburn Inc. | 2 | $142 |
| Lundbeck LLC | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Almatica Pharma LLC | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Biogen | 1 | $17 |
| Indivior Inc. | 1 | $16 |
| Corium, LLC | 1 | $15 |
| Exact Sciences | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$500
- VRAYLAR$250
- Auvelity$250
- CAPLYTA$239
- Austedo XR$228
- BRIXADI$125
- COBENFY$123
- SPRAVATO$122
- ABILIFY MAINTENA$115
- ABILIFY ASIMTUFII$115
How this compares
$3,628 in reported general payments places this provider in the 80th percentile of 443 psychiatric/mental health providers in Iowa.
Other psychiatric/mental health in Davenport
- Daniel WesemannDavenport$15K
- Stacy RothDavenport$4K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
- Jennifer BradleyCedar Rapids$66K
- Kama AusbornWaterloo$64K
- Quentin ChambersDes Moines$40K
- Tenaea JeppesonFort Dodge$38K
- Jennifer WittmanCoralville$25K
- Amy MorinCedar Rapids$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.